Introduction
============

Over the past decades, improvements have been made in the design and hemodynamics of mechanical valve prostheses in order to reduce valve dysfunction and increase durability \[[@b1-cm-89-169]\]. However, prosthetic stenosis due to thrombus or pannus is still one of the most frequent complications and it can be severe, evolving into cardiogenic shock \[[@b2-cm-89-169]--[@b7-cm-89-169]\]. Pannus is a non-immune inflammatory reaction of the body to the valve prosthesis, a proliferation of fibroelastic tissue and collagen, with a starting point in the suture area and subacute or chronic centripetal evolution \[[@b8-cm-89-169]\]. It usually proliferates on the ventricular side of aortic prostheses and is associated with certain risk factors such as operative technique, characteristics of the prosthesis, size of valves in patients with a small valve ring, young age, female sex, pregnancy, low cardiac output, turbulent flow, infection, inadequate anticoagulation \[[@b1-cm-89-169],[@b8-cm-89-169],[@b9-cm-89-169]\]. The differential diagnosis of pannus-related prosthetic valve dysfunction with other causes of prosthetic valve dysfunction, mainly thrombotic involvement, is frequently difficult but essential, because therapeutic approaches are different \[[@b10-cm-89-169],[@b11-cm-89-169],[@b12-cm-89-169]\].

Case report
===========

A 54-year-old patient from an urban area was brought by the ambulance to the service of cardiology for typical angina pain with onset about an hour before, after effort, without remission following nitroglycerin administration, associated with profuse sweating, nausea and vomiting.

We mention that the patient was known to the service of cardiology, as he had had a mechanical aortic prosthesis in place for 14 years, for aortic stenosis of rheumatic cause on a bicuspid valve, and ascending aortic aneurysm. The patient was last evaluated 3 years before, under the conditions of a similar angina episode, interpreted as non-ST segment elevation myocardial infarction (NSTEMI) syndrome, investigated by coronarography, with angiographically normal coronary arteries. At that time, echocardiography evidenced increased transprosthetic gradients: maximum pressure gradient(maxG)=88 mmHg, mean pressure gradient(meanG)=50 mmHg( normofunctional prosthesis range:\<20 mmHg), maximum velocity(vmax)=4 m/sec( normofunctional prosthesis range: \<3 m/sec), a moderate mismatch-indexed aortic valve orifice area=0.82 cm2/m2(moderate mismatch range: 0.65--0.85 cm2/m2)\[[@b13-cm-89-169]\], and a small size mass with a pannus appearance on the ventricular side of the prosthesis, which did not interfere with the disc movement. The current episode occurred in the context of repeated chest pain episodes over the past month, which were of lower intensity compared to the current episode, with a variable duration, during effort and rest, with spontaneous remission, accompanied by a decreased effort tolerance, the patient being asymptomatic until one month before. Daily medication at home consisted of oral anticoagulant (international normalized ratio (INR) values unchecked for the past 2 months), aspirin, converting enzyme inhibitor.

Objectively, the patient at admission was afebrile, dyspneic, with angina, blood pressure of 90/50 mmHg, ventricular rate of 70/min, audible prosthetic murmur, no pathological pulmonary changes, diffuse subendocardial injury on electrocardiogram(ECG) ([Figure 1](#f1-cm-89-169){ref-type="fig"}), emergency echocardiography: non-dilated left ventricle, with preserved ejection fraction, without significant regional kinetic disorders, dilated ascending aorta, without signs of dissection within 2 cm, increased transprosthetic gradients, biologically: unreacted myocardial enzymes in the first set(CK=142 UI/L, normal range: 10--190 UI/L; CK-MB=18 UI/L, normal range: 0--25 UI/L), normal aspartate aminotransferase(ASAT)(17 UI/L, normal range: 5--40 UI/L), alanin aminotransferase(ALAT)(17 UI/L, normal range: 5--41 UI/L), leukocytosis (12.42\*103/μL, normal range: 4.0--9.0\*103/μL), hyperglycemia (215 mg/dl, normal range: 74--106 mg/dl), INR value of 2.04 (therapeutic range: 2--3).

Coronarography evidenced a normal appearance of epicardial coronary arteries, similarly to previous coronarography, and an ample movement of the prosthetic disc. Aortic dissection was excluded by CT Angiography (CTA), infectious endocarditis and myocarditis were excluded clinically, biologically, echocardiographically. Gated Single-Photon Emission Computerized Tomography (*SPECT*) with Technetium (Tc)-99m evidenced hypokinesis of the inferior wall and of the interventricular septum, without perfusion defects or non-viable areas.

With anticoagulant, anti-aggregant, calcium blocker, antiarrhythmic treatment during hospitalization, the patient continued to present frequent pain episodes of very high intensity, which were relieved by major analgesics or sometimes remitted spontaneously, accompanied by reversible ECG changes ([Figures 2](#f2-cm-89-169){ref-type="fig"} and [3](#f3-cm-89-169){ref-type="fig"}).

Myocardial enzymes were reacted (peak values: CK-MB=318.9 UI/L; CK=2755 UI/L; Troponine I=2.59 ng/ml(normal range: ≤0.014 ng/ml), AST=243 UI/L, ALT=47 UI/L, subsequently on a continuous decrease. Leukocytes gradually normalized, the other tests being within the limits of reference values.

Repeated transthoracic echocardiography (TTE) was performed, which evidenced increased transprosthetic gradients consistent with severe aortic stenosis (maxG=70--92.7 mmHg, meanG=38--55.5 mmHg, vmax=4.2--4.9 m/sec, aortic regurgitation(AR) grade II due to intraprosthetic leak), moderate prosthesis-patient mismatch (0.67--0.8 cm2/m2), intermittent kinetic disorders in the inferior territory, and an echodense mass attached to the ventricular side of the prosthesis. Subsequently, transesophageal echocardiography (TOE) was performed, which allowed to visualize the interference of the mass with the closure of the prosthetic disc ([Figure 4](#f4-cm-89-169){ref-type="fig"}).

The patient was transferred to the service of cardiovascular surgery, where the stenosing subvalvular mass with a macroscopic pannus appearance, subsequently confirmed by microscopy ([Figure 5](#f5-cm-89-169){ref-type="fig"}), was surgically removed in extracorporeal circulation.

Postoperative evolution (at 2 months) was favorable, without the recurrence of pain complaints and the restoration of effort tolerance. TTE showed an improvement of transprosthetic gradients: maxG=55 mmHg, meanG=28 mmHg, vmax=3.7 m/sec, with the persistence of AR grade II, hemodynamic insignificant. No regional kinetic disorders were evidenced.

Discussion
==========

The case has several particular features. The discordance between repeated severe symptoms, ECG and enzymatic changes on the one hand, and the coronarographic and particularly, scintigraphic appearance on the other hand should be mentioned. The first 3 elements allow the diagnosis of acute myocardial infarction \[[@b14-cm-89-169]\]. Normal coronarographic appearance does not exclude the presence of endothelial erosions visible by intracoronary imaging methods such as intravascular ultrasound (IVUS) or optical coherence tomography (OCT) \[[@b15-cm-89-169]\], methods that were not applied in this case. Coronary spasm cannot be excluded, but there are several counter-arguments: it is frequently accompanied by ST segment elevation \[[@b16-cm-89-169]\], it was not evidenced during coronarography \[[@b17-cm-89-169]\], a procedure performed during the crisis, no response to anticalcium drugs \[[@b18-cm-89-169]\]. What was intriguing and made the diagnosis of infarction difficult was the almost white scintigraphic result, suggesting that the event that induced the enzymatic increase left no visible traces on scintigraphy. Transient kinetic disorders evidenced by some echocardiograms and by scintigraphy raised questions: interoperative variability or post-ischemic myocardial stunning.

While excluding other possible cardiovascular diseases and taking into consideration prosthetic valve dysfunction, which was the only abnormality found, with the remission of symptoms post-intervention, final differential diagnosis was required between the various causes of increased transprosthetic gradients: stenosis due to pannus and/or thrombus, prosthesis-patient mismatch (moderate, previously documented). Differential diagnosis between thrombus and pannus is made based on clinical, echocardiographic and morphopathological criteria ([Table I](#tI-cm-89-169){ref-type="table"}) \[[@b10-cm-89-169],[@b11-cm-89-169],[@b12-cm-89-169]\] and is essential because therapeutic approaches are different. If in thrombotic obstruction, thrombolysis can be considered, this is contraindicated in the case of pannus, where the only valid therapeutic option is surgery (valve replacement or pannus removal) \[[@b19-cm-89-169]\]. In our case, pannus was supported by chronic evolution, effective anticoagulation, subvalvular location at the level of the aortic prosthesis, non-interference with the opening of the prosthetic disc. In contrast, the acute evolution of symptoms, with frequent episodes occurring during rest, under the conditions of transprosthetic gradients approximately similar to those determined 3 years before, was not characteristic of uncomplicated pannus. A possible thrombotic association, with repeated microembolizations, in the absence of imaging or morphopathological evidence, remained hypothetical.

Therapeutic approach in case of severe stenosis due to pannus involves surgical reintervention, consisting of valve replacement or pannus removal. Valve replacement, a more complex procedure, is recommended only in certain conditions such as extensive circumferential pannus or a significantly altered prosthesis, based on the assumption of a marked inflammatory reaction in the case of replacement \[[@b1-cm-89-169]\]. In this case, pannus removal was the only option decided. An alternative could have been replacement with a larger size prosthesis, possibly with the previous enlargement of the aortic ring \[[@b1-cm-89-169],[@b20-cm-89-169]\], and/or a newer generation prosthesis, with intrinsically reduced transprosthetic gradients.

In conclusion, the presented case illustrates the problems that pannus-related prosthetic valve dysfunction, a late complication of mechanical prosthetic valve replacement, can pose in terms of clinical picture (severity, discordant elements), differential diagnosis, as well as optimal therapeutic approach.

![ECG at presentation, during chest pain, showing sinus rhythm with ST depression in leads V3-V6, DI, DII, aVF, AVL and ST elevation in aVR.](cm-89-169f1){#f1-cm-89-169}

![ECG during chest pain, showing remarkable ST changes-ST depression and T wave inversion, including leads V2 and DIII.](cm-89-169f2){#f2-cm-89-169}

![ECG after chest pain remission.](cm-89-169f3){#f3-cm-89-169}

![Transesophageal echocardiography. Interference of the mass with the closure of the prosthetic disc.](cm-89-169f4){#f4-cm-89-169}

![Hematoxylin and eosin staining, obx10. Microscopic aspect suggestive of pannus](cm-89-169f5){#f5-cm-89-169}

###### 

Differential diagnosis of pannus and thrombus \[[@b10-cm-89-169],[@b11-cm-89-169],[@b12-cm-89-169]\].

                                                      Pannus                                          Thrombus
  --------------------------------------------------- ----------------------------------------------- -------------------------------------------------------------
  **Chronology**                                      Minimum 12 months from date surgery             Occurs at any time (if late usually associated with pannus)
                                                                                                      
  **Evolution of symptoms**                           Subacute/chronic                                Acute
                                                                                                      
  **Relation with anticoagulation (low INR)**         Poor relationship                               Strong relationship
                                                                                                      
  **Location**                                        More frequent involving the aortic valve        More frequent involving the mitral valve
  Subvalvular                                         Supra or subvalvular                            
                                                                                                      
  **Morphology**                                      Small mass, undetected at TEE                   Larger mass than pannus, detected at TEE
  (semi)circular mass which involve the suture line   Irregular mass attached to valves/hinge point   
  Centripetal growth                                  Centrifugal growth                              
  Valve restriction can be absent                     Valve restriction                               
                                                                                                      
  **Echo density**                                    \>0.7                                           \<0.7 (PPV=87%)

PPV= positive predictive value
